A histone deacetylase 3 and mitochondrial complex I axis regulates toxic formaldehyde production.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
19 05 2023
Historique:
medline: 19 5 2023
pubmed: 17 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

Cells produce considerable genotoxic formaldehyde from an unknown source. We carry out a genome-wide CRISPR-Cas9 genetic screen in metabolically engineered HAP1 cells that are auxotrophic for formaldehyde to find this cellular source. We identify histone deacetylase 3 (HDAC3) as a regulator of cellular formaldehyde production. HDAC3 regulation requires deacetylase activity, and a secondary genetic screen identifies several components of mitochondrial complex I as mediators of this regulation. Metabolic profiling indicates that this unexpected mitochondrial requirement for formaldehyde detoxification is separate from energy generation. HDAC3 and complex I therefore control the abundance of a ubiquitous genotoxic metabolite.

Identifiants

pubmed: 37196082
doi: 10.1126/sciadv.adg2235
pmc: PMC10191432
doi:

Substances chimiques

histone deacetylase 3 EC 3.5.1.98
Histone Deacetylases EC 3.5.1.98
Electron Transport Complex I EC 7.1.1.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadg2235

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24455
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T032413/1
Pays : United Kingdom

Références

J Mass Spectrom. 1996 Mar;31(3):255-62
pubmed: 8799277
Mol Cell. 2014 Jul 17;55(2):253-63
pubmed: 24882210
Nature. 2017 Jun 22;546(7659):544-548
pubmed: 28614293
Mol Cell. 2015 Oct 1;60(1):177-88
pubmed: 26412304
Genome Biol. 2014;15(12):550
pubmed: 25516281
Science. 2001 Aug 31;293(5535):1653-7
pubmed: 11533489
Genome Biol. 2014;15(12):554
pubmed: 25476604
Anal Chem. 2007 Oct 1;79(19):7554-9
pubmed: 17822305
Nature. 2016 Apr 14;532(7598):255-8
pubmed: 27049945
J Biol Chem. 2007 Feb 16;282(7):4470-4478
pubmed: 17172643
Metab Eng. 2017 Sep;43(Pt B):187-197
pubmed: 27847310
J Pharm Sci. 2017 Sep;106(9):2245-2250
pubmed: 28495567
Chembiochem. 2010 Mar 1;11(4):506-10
pubmed: 20095001
Nat Commun. 2017 May 05;8:15178
pubmed: 28474669
Nat Commun. 2020 Jan 3;11(1):102
pubmed: 31900386
Nat Methods. 2018 Feb;15(2):134-140
pubmed: 29256493
Nature. 2021 Dec;600(7887):158-163
pubmed: 34819667
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Annu Rev Biochem. 2013;82:551-75
pubmed: 23527692
Cell. 1996 Nov 29;87(5):953-9
pubmed: 8945521
Biotechnol Bioeng. 2008 Feb 15;99(3):686-99
pubmed: 17787013
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11404-11409
pubmed: 29073064
Elife. 2017 Aug 15;6:
pubmed: 28826492
Nat Genet. 2017 Feb;49(2):193-203
pubmed: 27992415
Nat Rev Mol Cell Biol. 2019 Feb;20(2):102-115
pubmed: 30390028
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell. 2020 Jan 23;180(2):278-295.e23
pubmed: 31978345
Elife. 2014 May 13;3:e02242
pubmed: 24843020
J Biol Chem. 1974 Dec 10;249(23):7653-63
pubmed: 4373474
Nature. 2022 Jun;606(7913):382-388
pubmed: 35614220
Sci Adv. 2020 Dec 18;6(51):
pubmed: 33355142
Toxicol Pathol. 2013 Feb;41(2):181-9
pubmed: 23160431
Nature. 2017 Aug 31;548(7669):549-554
pubmed: 28813411
Mol Cell. 2020 Dec 17;80(6):996-1012.e9
pubmed: 33147438
Cell Metab. 2016 Jun 14;23(6):1140-1153
pubmed: 27211901
Nature. 2016 Aug 18;536(7616):354-358
pubmed: 27509854
BMC Biotechnol. 2001;1:7
pubmed: 11591226
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Genome Biol. 2007;8(9):R183
pubmed: 17784955
Bioinformatics. 2015 Sep 1;31(17):2912-4
pubmed: 25964631
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Nature. 2022 Jul;607(7920):756-761
pubmed: 35859172
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2647-52
pubmed: 23297220
Biochimie. 2013 Oct;95(10):1828-37
pubmed: 23791750
Blood. 2016 Dec 15;128(24):2774-2784
pubmed: 27756748

Auteurs

Niek Wit (N)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Ewa Gogola (E)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.

James A West (JA)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.

Tristan Vornbäumen (T)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.

Rachel V Seear (RV)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.

Peter S J Bailey (PSJ)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.

Guillermo Burgos-Barragan (G)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Meng Wang (M)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Department of Haematology, University of Cambridge, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.

Patrycja Krawczyk (P)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Daphne H E W Huberts (DHEW)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.

Fanni Gergely (F)

Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
Department of Biochemistry, University of Oxford, Oxford, UK.

Nicholas J Matheson (NJ)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
NHS Blood and Transplant, Cambridge, UK.

Arthur Kaser (A)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.
Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, UK.

James A Nathan (JA)

Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.

Ketan J Patel (KJ)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH